Copyright
©The Author(s) 2024.
World J Stem Cells. May 26, 2024; 16(5): 538-550
Published online May 26, 2024. doi: 10.4252/wjsc.v16.i5.538
Published online May 26, 2024. doi: 10.4252/wjsc.v16.i5.538
Figure 1 The expression of ankyrin repeat domain containing 26 varied in induced pluripotent stem cells derived from bone marrow and the urothelium.
A: Schematic structure of the 5’-untranslated region ankyrin repeat domain containing 26 (ANKRD26) region and its relationship with the Runt related transcription factor 1 (RUNX1) and friend leukemia integration 1 (FLI1) binding sites. The bases in red represent the mutation sites reported in the literature; B: Agarose gels after polymerase chain reaction to assess the expression of ANKRD26, RUNX1 and FLI1 in HEL, K562, human induced pluripotent stem cells derived from bone marrow, and human induced pluripotent stem cells derived from urothelium. UTR: Untranslated region; ANKRD26: Ankyrin repeat domain containing 26; RUNX1: Runt related transcription factor 1; FLI1: Friend leukemia integration 1; hiPSC-BM: Human induced pluripotent stem cells derived from bone marrow; hiPSC-U: Human induced pluripotent stem cells derived from urothelium.
- Citation: Jiang YZ, Hu LY, Chen MS, Wang XJ, Tan CN, Xue PP, Yu T, He XY, Xiang LX, Xiao YN, Li XL, Ran Q, Li ZJ, Chen L. GATA binding protein 2 mediated ankyrin repeat domain containing 26 high expression in myeloid-derived cell lines. World J Stem Cells 2024; 16(5): 538-550
- URL: https://www.wjgnet.com/1948-0210/full/v16/i5/538.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i5.538